Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
Heightened production of collagen and other matrix proteins underlies the fibrotic phenotype of systemic sclerosis (SSc). Roscovitine is an inhibitor of cyclin-dependent kinases that promote cell cycling (CDK1, 2), neuronal development (CDK5) and control transcription (CDK7,9). In an in vivo glomeru...
Main Authors: | Richard A Steinman, Andria Rasile Robinson, Carol A Feghali-Bostwick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3502367?pdf=render |
Similar Items
-
Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
by: Yinghua Song, et al.
Published: (2013-10-01) -
The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01) -
Fibroblasts in fibrosis: novel roles and mediators
by: Ryan Thomas Kendall, et al.
Published: (2014-05-01) -
Antifibrotic therapy to normalize the tumor microenvironment
by: Anette Hauge, et al.
Published: (2020-05-01) -
Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
by: Bahja Ahmed Abdi, et al.
Published: (2017-06-01)